1. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001
2. Pathophysiology of bone cancer pain;Sabino;J Support Oncol,2005
3. Hei YJ, Saad F, Coleman RE, et al. Fractures negatively affect survival in patients with bone metastases from breast cancer. Poster presented at: the 28th Annual San Antonio Breast Cancer Symposium; December 8-11, 2005; San Antonio, TX. Abstract #6036.
4. Saad F, Gleason D, Murray R, et al. Zoledronic acid provides longterm reductions in skeletal morbidity for men with prostate cancer and bone metastases. Poster presented at: American Society of Clinical Oncology 2006 Prostate Cancer Symposium; February 24-26, 2006; San Francisco, CA. Abstract #149.
5. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial;Kohno;J Clin Oncol,2005